Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Country - Austria
Summary - Ngs-Based Molecular Pathological Ce-Ivd Certified Tests* For The In-House Determination Of Hrd On Tissue Samples
Deadline - login to view
GT reference number - 80880918
Product classification - Data analysis services
Address - Austria
Contact details - 565656565
Tender notice no. - 76454545
GT Ref Id - 80880918
Document Type - Tender Notices
Description - Description: Procurement of NGS (next generation sequencing)-based molecular pathological CE-IVD certified tests* for the in-house determination of HRD (homologous recombination deficiency) on tissue samples (formalin-fixed and paraffin-embedded (FFP E) tumor tissue). The positive result of the test indicates an indication for treatment with a drug from the group of PARP inhibitors in the designated cancer types. The test must detect the following molecular parameters: Pathogenetically relevant mutations/aberrations in the genes BRCA1 and BRCA2 as well as other HRR-relevant genes, LOH (loss of heterozygosity), TAI (telomere allelic imbalance) and LST (large-scale state transitions). The plan
Gt Ref Id - 80880918
Deadline - Apr 30, 2024
Similar Tenders :
Join to access thousands of business opportunities
Why Us
3,00,000 +
Users
190 +
Countries Covered
5,00,000 +
Agencies Tracked
50,000 +
Notices Daily
90 Million +
Database
